These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15708701)

  • 1. Warning! Context-sensitive data.
    Mills RM
    J Am Coll Cardiol; 2005 Feb; 45(4):542-3. PubMed ID: 15708701
    [No Abstract]   [Full Text] [Related]  

  • 2. Long reach of the N-terminal of B-type natriuretic peptide.
    SoRelle R
    Circulation; 2002 Dec; 106(23):e9059. PubMed ID: 12460860
    [No Abstract]   [Full Text] [Related]  

  • 3. NT-proBNP in unstable coronary artery disease--experiences from the FAST, GUSTO IV and FRISC II trials.
    Jernberg T; James S; Lindahl B; Stridsberg M; Venge P; Wallentin L
    Eur J Heart Fail; 2004 Mar; 6(3):319-25. PubMed ID: 14987583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of natriuretic peptides in clinical decision-making for patients with non-ST-elevation acute coronary syndromes.
    de Lemos JA; Morrow DA
    Am Heart J; 2007 Apr; 153(4):450-3. PubMed ID: 17383278
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical significance of N-terminal pro-brain natriuretic peptide.
    Zhang XY; Zhu JH
    Chin Med J (Engl); 2004 Nov; 117(11):1716-22. PubMed ID: 15569492
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute coronary syndrome: the risk of being female.
    Elsaesser A; Hamm CW
    Circulation; 2004 Feb; 109(5):565-7. PubMed ID: 14769676
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum B-Type natriuretic peptide in STEMI patients treated with PCI.
    Grabowski M; Filipiak KJ; Karpinski G; Opolski G
    Cardiology; 2005; 103(3):120. PubMed ID: 15665531
    [No Abstract]   [Full Text] [Related]  

  • 8. The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study.
    West MJ; Nestel PJ; Kirby AC; Schnabel R; Sullivan D; Simes RJ; Pollicino C; Lubos E; Münzel TF; White HD; Tonkin AM; Bickel C; Tiret L; Blankenberg S;
    Eur Heart J; 2008 Apr; 29(7):923-31. PubMed ID: 18296678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-type natriuretic peptide and acute coronary syndromes.
    Kalra PR; Sharma R; Struthers AD
    N Engl J Med; 2002 Feb; 346(6):453-5. PubMed ID: 11837269
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes.
    Omland T; de Lemos JA; Morrow DA; Antman EM; Cannon CP; Hall C; Braunwald E
    Am J Cardiol; 2002 Feb; 89(4):463-5. PubMed ID: 11835931
    [No Abstract]   [Full Text] [Related]  

  • 11. The value of NT-proBNP in early risk stratification of acute coronary syndromes.
    Almeida R; Mariano L; Gavina C; Pinho T; Vasconcelos M; Ferreira A; Maciel MJ; Gonçalves FR
    Rev Port Cardiol; 2006 Jan; 25(1):71-5. PubMed ID: 16623357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recommendations for the clinical use of cardiac natriuretic peptides].
    Emdin M; Clerico A; Clemenza F; Galvani M; Latini R; Masson S; Mulè P; Panteghini M; Valle R; Zaninotto M; Ganau A; Mariotti R; Volpe M; Aspromonte N; Cacciatore G; Cappelletti P; L'Abbate A; Miglio F; Ottani F; Pagani F; Passino C; Plebani M; Sarzani R; Zucchelli G
    Ital Heart J Suppl; 2005 May; 6(5):308-25. PubMed ID: 15934430
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction.
    Anker SD; Coats AJ
    Circulation; 1997 Jan; 95(2):538-9. PubMed ID: 9008480
    [No Abstract]   [Full Text] [Related]  

  • 14. Brain natriuretic peptide and acute coronary syndrome.
    Mazzone M; Forte P; Portale G; Mancini F; Ursella S; La Sala M; Testa A; Covino M; Pignataro G; Gentiloni Silveri N
    Minerva Med; 2005 Feb; 96(1):11-8. PubMed ID: 15827538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina.
    Talwar S; Squire IB; Downie PF; Davies JE; Ng LL
    Heart; 2000 Oct; 84(4):421-4. PubMed ID: 10995414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cirrhotic cardiomyopathy: increased circulating pro-brain natriuretic peptide and brain natriuretic peptide in cirrhosis].
    Gøtze JP; Henriksen JH; Fuglsang S; Christensen E; Bendtsen F; Møller S
    Ugeskr Laeger; 2004 Aug; 166(35):2999-3002. PubMed ID: 15387012
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of clopidogrel on the rebound hypercoagulable state after heparin discontinuation in patients with acute coronary syndromes.
    Di Nisio M; Bijsterveld NR; Meijers JC; Levi M; Büller HR; Peters RJ
    J Am Coll Cardiol; 2005 Oct; 46(8):1582-3. PubMed ID: 16226189
    [No Abstract]   [Full Text] [Related]  

  • 18. N-terminal probrain natriuretic peptide as a predictor of short-term outcomes in acute myocardial infarction.
    Puri A; Narain VS; Mehrotra S; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2005; 57(4):304-10. PubMed ID: 16350675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future for B-type natriuretic peptide in preoperative assessment.
    Struthers KL; Choy AM; Lang CC
    Anesthesiology; 2008 Feb; 108(2):332; author reply 333. PubMed ID: 18212584
    [No Abstract]   [Full Text] [Related]  

  • 20. N-terminal pro-B-type natriuretic peptide and matrix metalloproteinases in early and late left ventricular remodeling after acute myocardial infarction.
    Tziakas DN; Chalikias GK; Hatzinikolaou EI; Stakos DA; Tentes IK; Kortsaris A; Hatseras DI; Kaski JC
    Am J Cardiol; 2005 Jul; 96(1):31-4. PubMed ID: 15979428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.